Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-27

Clinical Trial Update: Study Of Lybrel In Relation To Venous Thromboembolism

View source ↗

Summary

A completed clinical trial assessed whether Lybrel influences the risk of venous thromboembolism, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lybrel (ethinyl estradiol / levonorgestrel)

Snippet

Sponsor: Pfizer | Conditions: Venous Thrombosis, Pulmonary Embolism | Status: COMPLETED | Results posted: 2013-05-27